Use of the prognostic nutrition index as a predictive biomarker in small-cell lung cancer patients undergoing immune checkpoint inhibitor treatment in the Chinese alpine region.

Wu, Yunjiao; Yang, Jing; Qiao, Xinyi; Li, Yingjie; Zhao, Rui; Lin, Tie; Li, Xiaoli; Wang, Meng

Wu, Yunjiao; Yang, Jing; Qiao, Xinyi; Li, Yingjie; Zhao, Rui; Lin, Tie; Li, Xiaoli; Wang, Meng.

Affiliation

Wu Y; Department of Respiratory Medical Oncology, Harbin Medical University Cancer Hospital, Heilongjiang, Harbin, China.
Yang J; Chongqing Engineering Research Center for Processing and Storage of Distinct Agricultural Products, Chongqing Technology and Business University, Chongqing, China.
Qiao X; Department of Respiratory Medical Oncology, Harbin Medical University Cancer Hospital, Heilongjiang, Harbin, China.
Li Y; Department of Respiratory Medical Oncology, Harbin Medical University Cancer Hospital, Heilongjiang, Harbin, China.
Zhao R; Department of Respiratory Medical Oncology, Harbin Medical University Cancer Hospital, Heilongjiang, Harbin, China.
Lin T; Department of Surgery, The First Affiliated Hospital of Harbin Medical University, Heilongjiang, Harbin, China.
Li X; Department of Respiratory Medical Oncology, Harbin Medical University Cancer Hospital, Heilongjiang, Harbin, China.
Wang M; Department of Respiratory Medical Oncology, Harbin Medical University Cancer Hospital, Heilongjiang, Harbin, China.

Front Oncol ; 13: 1041140, 2023.

Article in En | MEDLINE | ID: mdl-37007079

Key words

PD-L1/PD-1 inhibitors; immune-related adverse events (irAEs); prognostic factor; prognostic nutritional index (PNI); small cell lung cancer (SCLC)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Front Oncol Year: 2023 Document type: Article Affiliation country: Country of publication:

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google